FDA Approved: CLOBEX — Supplemental Application (Galderma Laboratories, L.P.)

View source ↗

Summary

FDA approved a supplemental labeling change for Clobex (clobetasol propionate) by Galderma Laboratories.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Psoriasis

Drugs mentioned

• CLOBEX (clobetasol propionate)

Snippet

SUPPL AP for CLOBEX (CLOBETASOL PROPIONATE)